Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Hypersensitivity Pneumonitis Workup

  • Author: Caleb Hsieh, MD, MS; Chief Editor: Ryland P Byrd, Jr, MD  more...
 
Updated: Jan 20, 2015
 

Laboratory Studies

There are no unique diagnostic labs for the diagnosis of HP. Neutrophilia is common acute. Nonspecific markers of inflammation such as erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) are also observed in many patients. It should be noted that peripheral blood eosinophilia is often absent. Elevated quantitative serum immunoglobulins have been reported.

Diagnostic criteria

Various diagnostic criteria have been proposed for HP; however, definitive consensus guidelines have yet to be established by the major thoracic or immunological societies. In general, the diagnosis of HP remains heavily dependent on clinical judgment. That said, each of the proposed diagnostic criteria incorporate some subset of the following:

  • Exposure to a known offending antigen
    • Confirmed history of exposure
    • Positive precipitating antibodies to the offending antigen
    • Recurrent episodes of symptoms
  • Clinical signs and symptoms on physical examination and history
    • Crackles
    • Weight loss
    • Wheezing (generally less prominent feature)
    • Febrile episodes
    • Symptoms occurring within 4-8 hours of exposure
  • Radiographic evidence on chest radiograph or CT
  • Bronchoscopic alveolar lavage (BAL) evidence
    • Lymphocytic predominance
  • Pathologic evidence
    • Often evidence of poorly formed noncaseating granulomas
    • Mononuclear cellular infiltrates
    • Fibrotic scarring

In areas of especially high incidence, a high degree of suspicion may obviate the need for more invasive testing with BAL or biopsy.[39]

Precipitating antibodies against potential antigens may be present in serum and BAL specimens. Antibodies may be present in up to 40-50% of exposed individuals, even those without disease. Precipitins thus indicate prior exposure and sensitization but do not necessarily represent active disease. This is further confounded by the fact that many patients with clinical disease have no detectable antibodies, because of either testing with an inappropriate antibody or cessation of exposure. Some groups suggest testing for a wider array of precipitins to increase sensitivity; however, utility and cost-effectiveness have yet to be verified. Some centers may offer ELISA testing, which can be more sensitive for precipitins.

Next

Imaging Studies

Chest radiography

No findings on chest radiograph that are typical of HP. That said, pleural effusions, pleural thickening, or significant hilar adenopathy are rare in HP and may suggest alternative differential diagnoses.

In acute HP, a poorly defined micronodular or diffuse interstitial pattern is typical. Lower to middle lung zone predominance is variably reported and may be better appreciated in high-resolution CT scans. Findings are normal in approximately 10% of patients. Radiograph findings may also revert back to normal following resolution of the acute episode.

Subacute HP chest radiographs may be similar to acute HP with a predominantly reticulonodular pattern.[40] Note the image below:

A 60-year-old dairy farmer had an 8-year history o A 60-year-old dairy farmer had an 8-year history of intermittent dyspnea. Chest radiograph shows bilateral reticulonodular interstitial infiltration secondary to subacute hypersensitivity pneumonitis.

In chronic HP, progressive fibrotic changes with loss of lung volume and coarse linear opacities are common. Features of emphysema are found on significant chest films and CT scans. Note the image below:

Chest radiograph of a patient with chronic hyperse Chest radiograph of a patient with chronic hypersensitivity pneumonitis from pigeon breeder's disease. Bilateral reticulonodular densities are present.

High-resolution CT scanning

Nonspecific ground-glass opacities or diffusely increased radiodensities are present in the acute phase of disease.[41] Opacities may be either central or peripheral, but tend to involve the lower lobes preferentially to upper lobes. This may be suggestive of correlation with inhaled antigen load. Note the image below:

High-resolution CT scan of lungs shows ground-glas High-resolution CT scan of lungs shows ground-glass opacification in the acute phase of hypersensitivity pneumonitis.

In subacute disease, diffuse micronodules, ground-glass attenuation, focal air trapping, mosaic perfusion, occasional thin-walled cyst, and mild fibrotic changes are observed.

In chronic hypersensitivity pneumonitis, several patterns may be observed, including multiple centrilobular nodules with some ground-glass attenuation, radiolucency or air trapping, extensive fibrosis, traction bronchiectasis, and honeycombing.[42] Note the images below:

The chronic phase of hypersensitivity pneumonitis The chronic phase of hypersensitivity pneumonitis shows honeycombing in the right upper lung and traction bronchiectasis.
High-resolution chest CT scan of a patient with su High-resolution chest CT scan of a patient with subacute hypersensitivity pneumonitis demonstrates centrilobular nodules. These nodules are unlike those of sarcoidosis, in which the nodules are subpleural and along bronchovascular bundles.

It may be difficult to distinguish imaging features of HP from those of NSIP and IPF; thus, these should be considered as well. Features that may favor HP include mosaic perfusion, upper- or mid-zone predominance, centrilobar nodules and air-trapping.

Previous
Next

Other Tests

Pulmonary function studies

A restrictive ventilatory pattern, with reduced forced vital capacity, total lung capacity, and preserved airflow, is observed in acute or subacute disease. A restrictive (severe) or a mixed obstructive and restrictive pattern is common in chronic hypersensitivity pneumonitis. Diffusing capacity of lungs for carbon monoxide is reduced in all forms of hypersensitivity pneumonitis. Many patients have hypoxemia at rest, and most patients desaturate with exercise.

Previous
Next

Procedures

Inhalation challenge

Re-exposure to the environment of the supposed agent may help establish a causal relationship between symptoms and the environment. Inpatient inhalation of known antigens has been suggested as a way to observe reactions in a controlled setting. However, as of yet, no standardized antigen preparations are available. Patients generally develop fever, malaise, headache, crackles upon chest examination, and decreased forced vital capacity 8-12 hours after exposure. Although potentially helpful for diagnosis, re-exposure must be attempted with caution given the risk of severe attack an dprepensity fo rdisease progression.

Bronchoalveolar lavage

BAL may provide supportive information for the diagnosis of hypersensitivity pneumonitis.[43, 44] Initial BAL in the acute phase may be remarkable for more than 5% neutrophils. This is generally followed by marked lymphocytosis.

The characteristic BAL found in HP is a lymphocytosis with at least 20% and generally over 50% of white blood cells. This finding makes IPF less likely, but other conditions such as sarcoidosis, silicosis, or the organizing pneumonias may have similar white count profiles.

Otherwise, mast cells, eosinophils, and plasma cells are also characteristically seen in HP. Mast cells are also often characteristic of acute exposures as their numbers tend to decline within approximately 3 months of exposure. The presence of mast cells may help distinguish HP from organizing pneumonias. Eosinophilia may be present in conjunction with neutrophilia. The presence of plasma cells often correlates with immunoglobulin levels. High levels if IgA, IgG, IgM and free light chains in the presence of plasma cells may further favor a diagnosis of active HP.

Use of CD4+/CD8+ ratios for diagnosis of HP is controversial. Some evidence suggests that a ratio of < 1.0 (ie, predominance of CD8+) is consistent with acute/subacute disease, whereas a CD4+ predominance and high CD4+/CD8+ ratio occurs most often in chronic disease. The trend has been away from using the CD4+/CD8+ ratio recently, as it is beleived that too many factors, including type of antigen, severity of exposure, and disease stage, confound interpretation. Thus, interpretation of CD4+/CD8+ ratio is generally not effective.

Lung biopsy

Lung biopsy is rarely necessary, especially for acute cases, but it can be effective in cases in which usual studies are inconclusive. Transbronchial biopsy has fair diagnostic yield in acute and subacute disease. Yield can be maximized with multiple samples (usually 6 or more) from the most affected lobes as determined by imaging. Surgical open lung biopsy or video-assisted thoracic surgery (VATS) biopsy may provide higher yield in chronic disease or when high-resolution CT scanning (HRCT) findings are not typical for hypersensitivity pneumonitis.[45] The diagnostic utility of these more invasive procedures should always be decided via discussion between the pulmonologist and surgeon.

Previous
Next

Histologic Findings

Histologic findings for acute hypersensitivity pneumonitis, subacute hypersensitivity pneumonitis, and chronic hypersensitivity pneumonitis are as follows:[46]

  • Acute HP: Because biopsy is generally not indicated, relatively little is known about the gross pathologic features of acute HP. The most characteristic pathologic feature is neutrophilic interstitial infiltrate. Other features may include small-vessel vasculitis with immunoglobulin and complement deposition, diffuse alveolar damage, and/or intraalveolar fibrin accumulation. [7] Note the image below.
    Light microscopy shows mononuclear infiltration an Light microscopy shows mononuclear infiltration and noncaseating granulomas usually observed in association with acute hypersensitivity pneumonitis, but it also can be observed in subacute and chronic disease.
  • Subacute HP: Subacute HP characteristically reveals a triad of diffuse lymphocyte-dominant interstitial inflammatory cell infiltration, poorly formed nonnecrotizing granulomas, and cellular bronchiolitis. Foci of bronchiolitis obliterans and intra-alveolar fibrosis also are described. [7] Granulomas may be absent in as many as 30% of biopsies. It has been suggested that staining with cathepsin K may increase detection of microgranulomas. [2] Plasma cells, mast cells, giant cells, B-cell follicular formations, and bronchiolitis obliterans may also be noted.
  • Chronic HP: The pathological features of chronic HP include a usual interstitial pneumonia–like pattern with subpleural patchy fibrosis, honeycombing, alternating normal alveoli, and fibroblastic foci with centrilobular fibrosis. These fibrotic changes may be superimposed on findings of subacute HP or may often be indistinguishable from UIP. In contrast to acute and subacute HP, granulomas may be sparse or absent. Interstitial multinucleated giant cells often containing cholesterol clefts strongly suggest HP. Bridging fibrosis between peribronchiolar areas and perilobular areas also favor a diagnosis of HP over IPF. [7] Note the images below.
    Giant cells are a characteristic feature of hypers Giant cells are a characteristic feature of hypersensitivity pneumonitis.
    Chronic hypersensitivity pneumonitis shows interst Chronic hypersensitivity pneumonitis shows interstitial inflammation associated with fibrosis.
Previous
 
 
Contributor Information and Disclosures
Author

Caleb Hsieh, MD, MS Department of Internal Medicine, Olive View-UCLA Medical Center

Caleb Hsieh, MD, MS is a member of the following medical societies: American College of Physicians, American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Nader Kamangar, MD, FACP, FCCP, FCCM Professor of Clinical Medicine, University of California, Los Angeles, David Geffen School of Medicine; Chief, Division of Pulmonary and Critical Care Medicine, Vice-Chair, Department of Medicine, Olive View-UCLA Medical Center

Nader Kamangar, MD, FACP, FCCP, FCCM is a member of the following medical societies: Academy of Persian Physicians, American Academy of Sleep Medicine, American Association for Bronchology and Interventional Pulmonology, American College of Chest Physicians, American College of Critical Care Medicine, American College of Physicians, American Lung Association, American Medical Association, American Thoracic Society, Association of Pulmonary and Critical Care Medicine Program Directors, Association of Specialty Professors, California Sleep Society, California Thoracic Society, Clerkship Directors in Internal Medicine, Society of Critical Care Medicine, Trudeau Society of Los Angeles, World Association for Bronchology and Interventional Pulmonology

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Daniel R Ouellette, MD, FCCP Associate Professor of Medicine, Wayne State University School of Medicine; Chair of the Clinical Competency Committee, Pulmonary and Critical Care Fellowship Program, Senior Staff and Attending Physician, Division of Pulmonary and Critical Care Medicine, Henry Ford Health System; Chair, Guideline Oversight Committee, American College of Chest Physicians

Daniel R Ouellette, MD, FCCP is a member of the following medical societies: American College of Chest Physicians, Society of Critical Care Medicine, American Thoracic Society

Disclosure: Nothing to disclose.

Chief Editor

Ryland P Byrd, Jr, MD Professor of Medicine, Division of Pulmonary Disease and Critical Care Medicine, James H Quillen College of Medicine, East Tennessee State University

Ryland P Byrd, Jr, MD is a member of the following medical societies: American College of Chest Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Additional Contributors

Michael Peterson, MD Chief of Medicine, Vice-Chair of Medicine, University of California, San Francisco, School of Medicine; Endowed Professor of Medicine, University of California, San Francisco-Fresno, School of Medicine

Michael Peterson, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Acknowledgements

Marine Demirjian, MD Resident Physician, Department of Internal Medicine, Ronald Reagan University of California in Los Angeles Medical Center

Marine Demirjian, MD is a member of the following medical societies: American College of Physicians, American Medical Association, American Medical Women's Association, and California Medical Association

Disclosure: Nothing to disclose.

Sat Sharma, MD, FRCPC Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St Boniface General Hospital

Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association

Disclosure: Nothing to disclose.

References
  1. Schullian DM. Farmer’s Lung Disease: A new historical perspective from Iceland. J Hist Med. 1982.

  2. Selman M, Pardo A, King TE Jr. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012 Aug 15. 186(4):314-24. [Medline].

  3. Blatman KH, Grammer LC. Chapter 19: Hypersensitivity pneumonitis. Allergy Asthma Proc. 2012 May-Jun. 33 Suppl 1:S64-6. [Medline].

  4. Lacasse Y, Girard M, Cormier Y. Recent advances in hypersensitivity pneumonitis. Chest. 2012 Jul. 142(1):208-17. [Medline].

  5. Basis of Disease. Kumar V, Abbas AK, Fausto N, Aster JC, eds. Robbins and Cotran Pathologic. 8th ed. Philadelphia, Pa: Saunders; 2010.

  6. Adkinson NF. Hypersensitivity Pneumonitis. Middleton's Allergy: Principles and Practice. 8th Ed. Saunders; 2013.

  7. Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med. 2008 Sep. 14(5):440-54. [Medline].

  8. Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol. 2008 Sep. 39(9):1275-94. [Medline].

  9. Churg A, Muller NL, Flint J, Wright JL. Chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2006 Feb. 30(2):201-8. [Medline].

  10. Ohshimo S, Bonella F, Guzman J, Costabel U. Hypersensitivity Pneumonitis. Immunol Allergy Clin N Am. 2012. 32:537-556.

  11. Lacasse Y, Cormier Y. Hypersensitivity pneumonitis. Orphanet J Rare Dis. 2006. 1:25. [Medline].

  12. Gruchow HW, Hoffmann RG, Marx JJ Jr, Emanuel DA, Rimm AA. Precipitating antibodies to farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis. 1981 Oct. 124(4):411-5. [Medline].

  13. Gerke AK, Hunninghake GW. Hypersensitivity Pneumonitis and Pulmonary Infiltrates with Eosinophilia. Harrison’s Principles of Internal Medicine. 18th ed. McGraw-Hill Global Education Holdings;

  14. Dalphin JC, Debieuvre D, Pernet D, et al. Prevalence and risk factors for chronic bronchitis and farmer's lung in French dairy farmers. Br J Ind Med. 1993 Oct. 50(10):941-4. [Medline].

  15. Depierre A, Dalphin JC, Pernet D, Dubiez A, Faucompre C, Breton JL. Epidemiological study of farmer's lung in five districts of the French Doubs province. Thorax. 1988 Jun. 43(6):429-35. [Medline]. [Full Text].

  16. Terho EO. Work-related respiratory disorders among Finnish farmers. Am J Ind Med. 1990. 18(3):269-72. [Medline].

  17. Xaubet A, Ancochea J, Morell F, et al. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis. 2004 Mar. 21(1):64-70. [Medline].

  18. Olson AL, Huie TJ, Groshong SD, Cosgrove GP, Janssen WJ, Schwarz MI. Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest. 2008 Oct. 134(4):844-50. [Medline].

  19. Hanley A, Hubbard RB, Navaratnam V. Mortality trends in asbestosis, extrinsic allergic alveolitis and sarcoidosis in England and Wales. Respir Med. 2011 Sep. 105(9):1373-9. [Medline].

  20. Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax. 2005 Aug. 60(8):665-71. [Medline].

  21. Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc. 2007 Jul. 82(7):812-6. [Medline].

  22. Ganier M, Lieberman P, Fink J, Lockwood DG. Humidifier lung. An outbreak in office workers. Chest. 1980 Feb. 77(2):183-7. [Medline].

  23. Kane GC, Marx JJ, Prince DS. Hypersensitivity pneumonitis secondary to Klebsiella oxytoca. A new cause of humidifier lung. Chest. 1993 Aug. 104(2):627-9. [Medline].

  24. Rose CS, Martyny JW, Newman LS, et al. "Lifeguard lung": endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health. 1998 Dec. 88(12):1795-800. [Medline].

  25. Gamboa PM, de las Marinas MD, Antepara I, Jauregui I, Sanz MM. Extrinsic allergic alveolitis caused by esparto (Stipa tenacissima). Allergol Immunopathol (Madr). 1990 Nov-Dec. 18(6):331-4. [Medline].

  26. Zamarron C, del Campo F, Paredes C. Extrinsic allergic alveolitis due to exposure to esparto dust. J Intern Med. 1992 Aug. 232(2):177-9. [Medline].

  27. Rosenman KD. Asthma, hypersensitivity pneumonitis and other respiratory diseases caused by metalworking fluids. Curr Opin Allergy Clin Immunol. 2009 Apr. 9(2):97-102. [Medline].

  28. Roussel S, Reboux G, Dalphin JC, Pernet D, Laplante JJ, Millon L. Farmer's lung disease and microbiological composition of hay: a case-control study. Mycopathologia. 2005 Nov. 160(4):273-9. [Medline].

  29. Cappelluti E, Fraire AE, Schaefer OP. A case of "hot tub lung" due to Mycobacterium avium complex in an immunocompetent host. Arch Intern Med. 2003 Apr 14. 163(7):845-8. [Medline].

  30. Embil J, Warren P, Yakrus M, et al. Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hypersensitivity pneumonitis or infection?. Chest. 1997 Mar. 111(3):813-6. [Medline].

  31. Jacobs RL, Thorner RE, Holcomb JR, Schwietz LA, Jacobs FO. Hypersensitivity pneumonitis caused by Cladosporium in an enclosed hot-tub area. Ann Intern Med. 1986 Aug. 105(2):204-6. [Medline].

  32. Kahana LM, Kay JM, Yakrus MA, Waserman S. Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure. Chest. 1997 Jan. 111(1):242-5. [Medline].

  33. Khoor A, Leslie KO, Tazelaar HD, Helmers RA, Colby TV. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol. 2001 May. 115(5):755-62. [Medline].

  34. Travaline JM, Kelsen SG. Hypersensitivity pneumonitis associated with hot tub use. Arch Intern Med. 2003 Oct 13. 163(18):2250; author reply 2250-1. [Medline].

  35. Marras TK, Wallace RJ Jr, Koth LL, Stulbarg MS, Cowl CT, Daley CL. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest. 2005 Feb. 127(2):664-71. [Medline].

  36. Lee DK. Nicotine and hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2004 Jul 15. 170(2):199-200; author reply 200. [Medline].

  37. Terho EO, Husman K, Vohlonen I. Prevalence and incidence of chronic bronchitis and farmer's lung with respect to age, sex, atopy, and smoking. Eur J Respir Dis Suppl. 1987. 152:19-28. [Medline].

  38. Malmberg P. Health effects of organic dust exposure in dairy farmers. Am J Ind Med. 1990. 17(1):7-15. [Medline].

  39. Jacobsen G, Schlunssen V, Schaumburg I, Sigsgaard T. Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood. Eur Respir J. 2009 Jun. 33(6):1268-76. [Medline].

  40. Silva CI, Churg A, Müller NL. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. AJR Am J Roentgenol. 2007 Feb. 188(2):334-44. [Medline].

  41. Lynch DA, Rose CS, Way D, King TE Jr. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol. 1992 Sep. 159(3):469-72. [Medline].

  42. Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Munoz X. Bird fancier's lung: a series of 86 patients. Medicine (Baltimore). 2008 Mar. 87(2):110-30. [Medline].

  43. D'Ippolito R, Chetta A, Foresi A, et al. Induced sputum and bronchoalveolar lavage from patients with hypersensitivity pneumonitis. Respir Med. 2004 Oct. 98(10):977-83. [Medline].

  44. Lalancette M, Carrier G, Laviolette M, et al. Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors. Am Rev Respir Dis. 1993 Jul. 148(1):216-21. [Medline].

  45. Trahan S, Hanak V, Ryu JH, Myers JL. Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest. 2008 Jul. 134(1):126-32. [Medline].

  46. Grunes D, Beasley MB. Hypersensitivity pneumonitis: a review and update of histologic findings. J Clin Pathol. 2013 Oct. 66(10):888-95. [Medline].

  47. Monkare S. Influence of corticosteroid treatment on the course of farmer's lung. Eur J Respir Dis. 1983 May. 64(4):283-93. [Medline].

  48. Semenzato G, Bjermer L, Costabel U, Haslam PL, Olivieri D. Clinical guidelines and indications for bronchoalveolar lavage (BAL): extrinsic allergic alveolitis. Eur Respir J. 1990 Sep. 3(8):945-6, 961-9. [Medline].

  49. [Guideline] Brown KK. Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan. 129(1 Suppl):180S-185S. [Medline].

  50. [Guideline] Tarlo SM. Cough: occupational and environmental considerations: ACCP evidence-based clinical practice guidelines. Chest. 2006 Jan. 129(1 Suppl):186S-196S. [Medline].

  51. Wang P, Xu ZJ, Xu WB, et al. Clinical features and prognosis in 21 patients with extrinsic allergic alveolitis. Chin Med Sci J. 2009 Dec. 24(4):202-7. [Medline].

  52. Sahin H, Brown KK, Curran-Everett D, et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology. 2007 Aug. 244(2):591-8. [Medline].

  53. Hanak V, Golbin JM, Hartman TE, Ryu JH. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest. 2008 Jul. 134(1):133-8. [Medline].

  54. Lima MS, Coletta EN, Ferreira RG, et al. Subacute and chronic hypersensitivity pneumonitis: histopathological patterns and survival. Respir Med. 2009 Apr. 103(4):508-15. [Medline].

  55. Alegre J, Morell F, Cobo E. Respiratory symptoms and pulmonary function of workers exposed to cork dust, toluene diisocyanate and conidia. Scand J Work Environ Health. 1990 Jun. 16(3):175-81. [Medline].

  56. Bang KM, Weissman DN, Pinheiro GA, Antao VC, Wood JM, Syamlal G. Twenty-three years of hypersensitivity pneumonitis mortality surveillance in the United States. Am J Ind Med. 2006 Dec. 49(12):997-1004. [Medline].

  57. Barbee RA, Callies Q, Dickie HA, Rankin J. The long-term prognosis in farmer's lung. Am Rev Respir Dis. 1968 Feb. 97(2):223-31. [Medline].

  58. Bourke SJ, Banham SW, Carter R, Lynch P, Boyd G. Longitudinal course of extrinsic allergic alveolitis in pigeon breeders. Thorax. 1989 May. 44(5):415-8. [Medline]. [Full Text].

  59. Buschman DL, Gamsu G, Waldron JA Jr, Klein JS, King TE Jr. Chronic hypersensitivity pneumonitis: use of CT in diagnosis. AJR Am J Roentgenol. 1992 Nov. 159(5):957-60. [Medline].

  60. Christensen LT, Schmidt CD, Robbins L. Pigeon breeders' disease--a prevalence study and review. Clin Allergy. 1975 Dec. 5(4):417-30. [Medline].

  61. Cormier Y, Belanger J. Long-term physiologic outcome after acute farmer's lung. Chest. 1985 Jun. 87(6):796-800. [Medline].

  62. Cormier Y, Belanger J, Tardif A, Leblanc P, Laviolette M. Relationships between radiographic change, pulmonary function, and bronchoalveolar lavage fluid lymphocytes in farmer's lung disease. Thorax. 1986 Jan. 41(1):28-33. [Medline]. [Full Text].

  63. Daman L, Lieberman P, Ganier M, Hashimoto K. Localized heat urticaria. J Allergy Clin Immunol. 1978 Apr. 61(4):273-8. [Medline].

  64. Fink JN. Hypersensitivity pneumonitis. Clin Chest Med. 1992 Jun. 13(2):303-9. [Medline].

  65. Fink JN, Ortega HG, Reynolds HY, Cormier YF, Fan LL, Franks TJ. Needs and opportunities for research in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2005 Apr 1. 171(7):792-8. [Medline].

  66. Gurney JW. Hypersensitivity pneumonitis. Radiol Clin North Am. 1992 Nov. 30(6):1219-30. [Medline].

  67. Hartman TE. The HRCT features of extrinsic allergic alveolitis. Semin Respir Crit Care Med. 2003 Aug. 24(4):419-26. [Medline].

  68. Hendrick DJ, Faux JA, Marshall R. Budgerigar-fancier's lung: the commonest variety of allergic alveolitis in Britain. Br Med J. 1978 Jul 8. 2(6130):81-4. [Medline].

  69. Klote M. Hypersensitivity pneumonitis. Allergy Asthma Proc. 2005 Nov-Dec. 26(6):493-5. [Medline].

  70. Krasnick J, Meuwissen HJ, Nakao MA, Yeldandi A, Patterson R. Hypersensitivity pneumonitis: problems in diagnosis. J Allergy Clin Immunol. 1996 Apr. 97(4):1027-30. [Medline].

  71. Kurup VP, Zacharisen MC, Fink JN. Hypersensitivity pneumonitis. Indian J Chest Dis Allied Sci. 2006 Apr-Jun. 48(2):115-28. [Medline].

  72. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2003 Oct 15. 168(8):952-8. [Medline].

  73. Madsen D, Klock LE, Wenzel FJ, Robbins JL, Schmidt CD. The prevalence of farmer's lung in an agricultural population. Am Rev Respir Dis. 1976 Feb. 113(2):171-74. [Medline].

  74. Malmberg P, Rask-Andersen A, Hoglund S, Kolmodin-Hedman B, Read Guernsey J. Incidence of organic dust toxic syndrome and allergic alveolitis in Swedish farmers. Int Arch Allergy Appl Immunol. 1988. 87(1):47-54. [Medline].

  75. Miyazaki Y, Tateishi T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest. 2008 Dec. 134(6):1265-70. [Medline].

  76. Morell F, Villar A, Montero MA, Munoz X, Colby TV, Pipvath S, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med. 2013 Nov. 1(9):685-94. [Medline].

  77. Moreno-Ancillol A, Dominguez-Noche C, Gil-Adrados AC, Cosmes PM. Hypersensitivity pneumonitis due to occupational inhalation of fungi-contaminated corn dust. J Investig Allergol Clin Immunol. 2004. 14(2):165-7. [Medline].

  78. Murayama J, Yoshizawa Y, Ohtsuka M, Hasegawa S. Lung fibrosis in hypersensitivity pneumonitis. Association with CD4+ but not CD8+ cell dominant alveolitis and insidious onset. Chest. 1993 Jul. 104(1):38-43. [Medline].

  79. [Guideline] Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Subcommittee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol. 1989 Nov. 84(5 Pt 2):839-44. [Medline].

  80. Rose CS. Water-related lung diseases. Occup Med. 1992 Apr-Jun. 7(2):271-86. [Medline].

  81. Salvaggio JE. Inhaled particles and respiratory disease. J Allergy Clin Immunol. 1994 Aug. 94(2 Pt 2):304-9. [Medline].

  82. Salvaggio JE. The identification of hypersensitivity pneumonitis. Hosp Pract (Minneap). 1995 May 15. 30(5):57-62, 65-6. [Medline].

  83. Salvaggio JE, Millhollon BW. Allergic alveolitis: new insights into old mysteries. Respir Med. 1993 Oct. 87(7):495-501. [Medline].

  84. Schlueter DP. Response of the lung to inhaled antigens. Am J Med. 1974 Sep. 57(3):476-92. [Medline].

  85. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med. 2004 Sep. 25(3):531-47, vi. [Medline].

  86. Sharma OP, Fujimura N. Hypersensitivity pneumonitis: a noninfectious granulomatosis. Semin Respir Infect. 1995 Jun. 10(2):96-106. [Medline].

  87. Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med. 2004 May 15. 116(10):662-8. [Medline].

  88. Woda BA. Hypersensitivity pneumonitis: an immunopathology review. Arch Pathol Lab Med. 2008 Feb. 132(2):204-5. [Medline].

 
Previous
Next
 
A 60-year-old dairy farmer had an 8-year history of intermittent dyspnea. Chest radiograph shows bilateral reticulonodular interstitial infiltration secondary to subacute hypersensitivity pneumonitis.
Chest radiograph of a patient with chronic hypersensitivity pneumonitis from pigeon breeder's disease. Bilateral reticulonodular densities are present.
High-resolution CT scan of lungs shows ground-glass opacification in the acute phase of hypersensitivity pneumonitis.
The chronic phase of hypersensitivity pneumonitis shows honeycombing in the right upper lung and traction bronchiectasis.
High-resolution chest CT scan of a patient with subacute hypersensitivity pneumonitis demonstrates centrilobular nodules. These nodules are unlike those of sarcoidosis, in which the nodules are subpleural and along bronchovascular bundles.
Light microscopy shows mononuclear infiltration and noncaseating granulomas usually observed in association with acute hypersensitivity pneumonitis, but it also can be observed in subacute and chronic disease.
Giant cells are a characteristic feature of hypersensitivity pneumonitis.
Chronic hypersensitivity pneumonitis shows interstitial inflammation associated with fibrosis.
Table. Selected Etiological Agents for Hypersensitivity Pneumonitis
Disease Source of Exposure Major Antigen
Farmer's lung Moldy hay Saccharopolyspora rectivirgula



(Micropolyspora faeni)



Bagassosis Moldy sugar cane fiber Thermoactinomyces sacchari
Grain handler's lung Moldy grain S rectivirgula,Thermoactinomyces vulgaris
Humidifier/air-conditioner lung Contaminated forced-air systems, heated water reservoirs S rectivirgula, T vulgaris
Bird breeder's lung Pigeons, parakeets, fowl, rodents Avian or animal proteins
Cheese worker's lung Cheese mold Penicillium casei
Malt worker's lung Moldy malt Aspergillus clavatus
Paprika splitter's lung Paprika dust Mucor stolonifer
Wheat weevil Infested wheat Sitophilus granarius
Mollusk shell hypersensitivity Shell dust Sea snail shells
Chemical worker's lung Manufacture of plastics, polyurethane foam, rubber Trimellitic anhydride, diisocyanate, methylene diisocyanate
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.